Bioerodible system for sequential release of multiple drugs

Producción científica: Articlerevisión exhaustiva

29 Citas (Scopus)

Resumen

Because many complex physiological processes are controlled by multiple biomolecules, comprehensive treatment of certain disease conditions may be more effectively achieved by administration of more than one type of drug. Thus, the objective of the present research was to develop a multilayered, polymer-based system for sequential delivery of multiple drugs. The polymers used were cellulose acetate phthalate (CAP) complexed with Pluronic F-127 (P). After evaluating morphology of the resulting CAPP system, in vitro release of small molecule drugs and a model protein was studied from both single and multilayered devices. Drug release from single-layered CAPP films followed zero-order kinetics related to surface erosion of the association polymer. Release studies from multilayered CAPP devices showed the possibility of achieving intermittent release of one type of drug as well as sequential release of more than one type of drug. Mathematical modeling accurately predicted the release profiles for both single layer and multilayered devices. The present CAPP association polymer-based multilayer devices can be used for localized, sequential delivery of multiple drugs for the possible treatment of complex disease conditions, and perhaps for tissue engineering applications, that require delivery of more than one type of biomolecule.

Idioma originalEnglish
Páginas (desde-hasta)115-125
Número de páginas11
PublicaciónActa Biomaterialia
Volumen10
N.º1
DOI
EstadoPublished - ene 2014

Nota bibliográfica

Funding Information:
This research was supported by NIH ( DE019645 and AR060964 ) and Kentucky NASA EPSCo R ( NNX08BA13A ). We dedicate this work in memory of Dr. Mark V. Thomas, who passed away as the studies were being conducted.

Financiación

This research was supported by NIH ( DE019645 and AR060964 ) and Kentucky NASA EPSCo R ( NNX08BA13A ). We dedicate this work in memory of Dr. Mark V. Thomas, who passed away as the studies were being conducted.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)DE019645
National Institute of Arthritis and Musculoskeletal and Skin DiseasesR01AR060964
Kentucky Space Grant ConsortiumNNX08BA13A

    ASJC Scopus subject areas

    • Biotechnology
    • Biomaterials
    • Biochemistry
    • Biomedical Engineering
    • Molecular Biology

    Huella

    Profundice en los temas de investigación de 'Bioerodible system for sequential release of multiple drugs'. En conjunto forman una huella única.

    Citar esto